Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease-Reference-Cited by-同舟云学术

Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease

Published:2016-07-25 Issue:3 Volume:80 Page:379-387
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Vlassenko Andrei G.¹²³,McCue Lena⁴,Jasielec Mateusz S.⁴,Su Yi¹,Gordon Brian A.¹³,Xiong Chengjie³⁴,Holtzman David M.²³⁵,Benzinger Tammie L. S.¹²³,Morris John C.²³⁵,Fagan Anne M.²³⁵

Affiliation:

1. Department of RadiologyWashington University School of MedicineSaint Louis MO

2. Hope Center for Neurological DisordersWashington University School of MedicineSaint Louis MO

3. Knight Alzheimer's Disease Research CenterWashington University School of MedicineSaint Louis MO

4. Division of BiostatisticsWashington University School of MedicineSaint Louis MO

5. Department of NeurologyWashington University School of MedicineSaint Louis MO

Funder

NIH

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.24719

Reference36 articles.

1. Contribution of Alzheimer disease to mortality in the United States

2. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

3. Where, when, and in what form does sporadic Alzheimerʼs disease begin?

4. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

5. Longitudinal Patterns of β-Amyloid Deposition in Nondemented Older Adults

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment;Journal of Alzheimer's Disease;2024-03-05

2. Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset;Annals of Neurology;2024-02-24

3. PET imagining in Alzheimer’s disease;Ukrainian Journal of Military Medicine;2023-12-29

4. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease;Science Translational Medicine;2023-07-05

5. Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease;Science Translational Medicine;2023-06-14